Recruiting

Observational Study

Sponsor:

University of Vermont

Code:

NCT01148407

Conditions

Cancer

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

Blood samples on persons with cancer will be sampled for angiogenic, metastatic and coagulation proteins.

Conditions

Cancer

Study ID

NCT01148407

Start date

Jun, 2010

Status verified date

Apr, 2011

Completion date

Aug, 2013

Anticipated

Primary completion date

Aug, 2012

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Patients with a diagnosis of malignancy

Exclusion Criteria:

  • Patients taking aspirin, NSAIDs, warfarin or platelet inhibitor therapy

Study Design

Enrollment

30 participants

Anticipated

Interventions and Outcome Measures

Central Contacts and Locations

Central contacts

Chris E Holmes, MD, PhD

802-656-0302ceholmes@uvm.edu

Locations

University of Vermont/Fletcher Allen Health Care

Recruiting

Burlington, Vermont, United States, 05401

Contacts

Barbara Kelly

bkelly@uvm.edu

Principal Investigator:

Chris E Holmes, MD PhD

More Information

Sponsor

University of Vermont

Last update posted

Apr 22, 2011

Last verified

Apr, 2011

Keywords

  • breast cancer
  • platelets
  • metastatic cancer
  • malignancy

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by University of Vermont on 2011-04-22.